Ovid Therapeutics Inc Cash Flow Quality Index

Latest as of December 2025: -1.08x

Ovid Therapeutics Inc cash flow quality index. Ovid Therapeutics Inc (OVID) has a Cash Flow Quality Index of -1.08x as of December 2025. Operating cash flow of $-10.41 Million is below net income of $9.66 Million, suggesting accrual-heavy earnings not yet converted to cash. See OVID financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-1.08x

Operating CF / Net Income

Operating Cash Flow

$-10.41 Million

USD

Net Income

$9.66 Million

USD

Data as of

Dec 2025

Most recent filing

Cash Flow Quality Index of Ovid Therapeutics Inc (2021–2021)

Cash flow quality index of Ovid Therapeutics Inc from 2021 to 2021. Historical Cash Flow Quality Index for Ovid Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Ovid Therapeutics Inc (OVID) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Ovid Therapeutics Inc Cash Flow Quality Index by Year (2021–2021)

Ovid Therapeutics Inc cash flow quality index by year from 2021 to 2021. Year-by-year earnings quality comparison for Ovid Therapeutics Inc. For the full cash flow conversion analysis, see Ovid Therapeutics Inc (OVID) cash conversion ratio.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change
2021	0.97x	$118.61 Million	$122.83 Million	—

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.